The Circadian Gene NPAS2 Act As a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma

Overview

Journal Cancer Manag Res

Publisher Dove Medical Press

Specialty Oncology

Date 2022 Jan 7

PMID 34992456

Citations 7

Authors

Xiaojiao Zheng

Xiuyi Lv

Linyan Zhu

Kejun Xu

Cong Shi

Lining Cui

Huiqing Ding

Affiliations

Soon will be listed here.

Abstract

Background: Mounting evidence indicates altered circadian rhythm represents a critical factor affecting carcinogenesis and tumor progression. The circadian gene neuronal PAS domain protein 2 (NPAS2) constitutes a newly discovered prognostic biomarker. NPAS2 dysregulation is found in multiple malignancies, although its functions in uterine corpus endometrial carcinoma (UCEC) remain largely unknown.

Objective: To evaluate NPAS2's roles in UCEC and to explore the underlying mechanisms.

Methods: NPAS2 transcription levels, patient prognosis, different clinical stages and target microRNAs in UCEC cases were comparatively assessed based on public databases, including UALCAN, GEPIA, TIMER, Kaplan-Meier plotter, starBase database, LinkedOmics and String. Then, qRT-PCR and immunohistochemical analysis were applied to analyze the expression of NPAS2 in UCEC tissue samples. CCK-8, clonogenic assay and flow cytometry were carried out for detecting cell viability, colony formation ability and cell apoptosis, respectively.

Results: NPAS2 was upregulated in tissue samples from UCEC cases compared with the corresponding control specimens. NPAS2 overexpression was associated with decreased overall (OS), disease free (DFS) and relapse free (RFS) survival in UCEC. In addition, NPAS2 overexpression was associated with clinical stage, tumor grade, estrogen receptor status, myometrial invasion in UCEC. Furthermore, NPAS2 knockdown or overexpression altered cell proliferation and apoptosis in UCEC. Moreover, NPAS2 showed significant negative correlations with miR-17-5p and miR-93-5p, and positive correlations with miR-106a-5p and miR-381-3p in UCEC.

Conclusion: NPAS2 overexpression is associated with poor prognosis and clinicopathological characteristics in UCEC and promotes proliferation and colony formation while inhibiting apoptosis. Finally, NPAS2 is associated with several miRNAs in UCEC.

Citing Articles

The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.

Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R Research (Wash D C). 2025; 8:0612.

PMID: 40046513 PMC: 11880593. DOI: 10.34133/research.0612.

Transcriptome profiling revealed multiple circadian rhythm-related genes associated with common gynecological cancers.

Peng L, Jiang M, Li K, Yu S, Zhao C, Zhang L Front Oncol. 2025; 15:1422122.

PMID: 39944833 PMC: 11813765. DOI: 10.3389/fonc.2025.1422122.

Role of Pyroptosis in Endometrial Cancer and Its Therapeutic Regulation.

Al Mamun A, Geng P, Wang S, Shao C J Inflamm Res. 2024; 17:7037-7056.

PMID: 39377044 PMC: 11457779. DOI: 10.2147/JIR.S486878.

Using single-sample networks to identify the contrasting patterns of gene interactions and reveal the radiation dose-dependent effects in multiple tissues of spaceflight mice.

Zhang Y, Zhao L, Sun Y NPJ Microgravity. 2024; 10(1):45.

PMID: 38575629 PMC: 10995210. DOI: 10.1038/s41526-024-00383-7.

LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.

Fu B, Zhou M, Geng X, Jiang Y, Zeng H, Zhou X Aging (Albany NY). 2024; 16(1):714-745.

PMID: 38217544 PMC: 10817406. DOI: 10.18632/aging.205414.

References

Zhang K, Cai Y, Zhou Q, Sun H, Wei J . Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ Axis. Cancer Manag Res. 2020; 12:9515-9525. PMC: 7534865. DOI: 10.2147/CMAR.S257419. View

De A, Beligala D, Sharma V, Burgos C, Lee A, Geusz M . Cancer stem cell generation during epithelial-mesenchymal transition is temporally gated by intrinsic circadian clocks. Clin Exp Metastasis. 2020; 37(5):617-635. DOI: 10.1007/s10585-020-10051-1. View

Bansal N, Yendluri V, Wenham R . The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 2008; 16(1):8-13. DOI: 10.1177/107327480901600102. View

Dioum E, Rutter J, Tuckerman J, Gonzalez G, Gilles-Gonzalez M, McKnight S . NPAS2: a gas-responsive transcription factor. Science. 2002; 298(5602):2385-7. DOI: 10.1126/science.1078456. View

Xue X, Liu F, Han Y, Li P, Yuan B, Wang X . Silencing NPAS2 promotes cell growth and invasion in DLD-1 cells and correlated with poor prognosis of colorectal cancer. Biochem Biophys Res Commun. 2014; 450(2):1058-62. DOI: 10.1016/j.bbrc.2014.06.104. View

Yuan P, Yang T, Mu J, Zhao J, Yang Y, Yan Z . Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells. Cancer Lett. 2019; 469:498-509. DOI: 10.1016/j.canlet.2019.11.024. View

Markowska A, Pawalowska M, Lubin J, Markowska J . Signalling pathways in endometrial cancer. Contemp Oncol (Pozn). 2014; 18(3):143-8. PMC: 4268999. DOI: 10.5114/wo.2014.43154. View

Reszka E, Przybek M, Muurlink O, Peplonska B . Circadian gene variants and breast cancer. Cancer Lett. 2017; 390:137-145. DOI: 10.1016/j.canlet.2017.01.012. View

Esquifino A, Selgas L, Arce A, Maggiore V, Cardinali D . Twenty-four-hour rhythms in immune responses in rat submaxillary lymph nodes and spleen: effect of cyclosporine. Brain Behav Immun. 1996; 10(2):92-102. DOI: 10.1006/brbi.1996.0010. View

10.

Kelleher F, Rao A, Maguire A . Circadian molecular clocks and cancer. Cancer Lett. 2013; 342(1):9-18. DOI: 10.1016/j.canlet.2013.09.040. View

11.

Zheng X, Xu K, Zhu L, Mao M, Zhang F, Cui L . MiR-486-5p Act as a Biomarker in Endometrial Carcinoma: Promotes Cell Proliferation, Migration, Invasion by Targeting MARK1. Onco Targets Ther. 2020; 13:4843-4853. PMC: 7266516. DOI: 10.2147/OTT.S246841. View

12.

Zhu Y, Leaderer D, Guss C, Brown H, Zhang Y, Boyle P . Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma. Int J Cancer. 2006; 120(2):432-5. PMC: 2375536. DOI: 10.1002/ijc.22321. View

13.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

14.

Vasaikar S, Straub P, Wang J, Zhang B . LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2017; 46(D1):D956-D963. PMC: 5753188. DOI: 10.1093/nar/gkx1090. View

15.

Lanczky A, Gyorffy B . Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021; 23(7):e27633. PMC: 8367126. DOI: 10.2196/27633. View

16.

Baker F, Driver H . Circadian rhythms, sleep, and the menstrual cycle. Sleep Med. 2007; 8(6):613-22. DOI: 10.1016/j.sleep.2006.09.011. View

17.

Bokhman J . Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983; 15(1):10-7. DOI: 10.1016/0090-8258(83)90111-7. View

18.

Hoffman A, Zheng T, Ba Y, Zhu Y . The circadian gene NPAS2, a putative tumor suppressor, is involved in DNA damage response. Mol Cancer Res. 2008; 6(9):1461-8. PMC: 2572675. DOI: 10.1158/1541-7786.MCR-07-2094. View

19.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

20.

Bence Lin A, McNeely S, Beckmann R . Achieving Precision Death with Cell-Cycle Inhibitors that Target DNA Replication and Repair. Clin Cancer Res. 2017; 23(13):3232-3240. DOI: 10.1158/1078-0432.CCR-16-0083. View